New WHO autoantibody reference reagent will benefit SLE patients
Reference reagents are important in diagnostics and care of patients with systemic lupus erythematosus (SLE). An international team of researchers now presents a WHO autoantibody reference reagent that will help to align autoantibody analyses and thus to optimise diagnosis and treatment to patients irrespective of where they live. The findings are published in Annals of the Rheumatic Diseases.